FDA accepts Polivy in combination with R-CHP for DLBCL
ADC评论
August 17, 2022
FDA accepts supplemental Biologics License Application for Roche’s Polivy combination for people with previously untreated diffuse large B-cell lymphoma The Food and Drug Administration (FDA)
